Infectious disease
Lenacapavir Turns HIV Prevention Into an Access Stress Test
Global Fund and U.S. support for twice-yearly injectable PrEP could reshape HIV prevention, but the rollout also exposes the hard politics of supply, prioritisation, generic access and equitable delivery.
WHO’s New AMR Plan Makes Stewardship and Access a Single Test
Hepatitis B Functional Cure Moves Closer, But Access Still Starts With Diagnosis
Ebola PHEIC Turns Outbreak Control Into a Preparedness Test
The AMR Pipeline Is Too Thin for the Threat Ahead
TB Diagnosis Moves Closer to the Patient
Hepatitis Elimination Is Still Losing Patients Before Diagnosis
Lenacapavir Turns HIV Prevention Into an Access Stress Test
WHO’s AMR Plan Turns Access Into Preparedness
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.